Oscar Health, Inc. reported $15.3B of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $15.3B (to Q2 2026). Net income: $551M, trailing twelve months to Q2 2026. Free cash flow: $4.38B, trailing twelve months to Q2 2026. Operating margin: 1.7%, trailing twelve months to Q2 2026.

OSCROscar Health, Inc.

Healthcare

$33.35+76% 1Y

$33.35

$10.8552 weeks$33.81

OSCR as reported

Oscar Health, Inc. reported $15.3B of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed.

$15.3B

Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before

Net income: $551M
Net income · −442% year on year · trailing twelve months to Q2 2026
Free cash flow: $4.38B
Free cash flow · +265% year on year · trailing twelve months to Q2 2026
Operating margin: 1.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for OSCR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$15.3B	+43%	Q2 2026
Net income	$551M	−442%	Q2 2026
EPS	$1.30	−276%	Q2 2026
Operating margin	1.7%	n/a	Q2 2026
Net margin	1.2%	n/a	Q2 2026
ROE	−11%	n/a	Q2 2026
ROA	−1.7%	n/a	Q2 2026
ROIC	4.1%	n/a	Q2 2026
Free cash flow	$4.38B	+265%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.